{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:20:37Z","timestamp":1792920037222,"version":"4.5.0"},"reference-count":181,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Epstein-Barr Virus (EBV) is an extremely successful human herpes virus, which infects essentially all human beings at some time during their life span. EBV infection and the associated immune response results in production of antibodies (seroconversion), which occurs mainly during the first years of life, but may also happen during adolescence or later in life. Infection of adolescents can result in infectious mononucleosis, an acute serious condition characterized by massive lymphocytosis. Transmission of EBV mainly occurs through saliva but can rarely be spread through semen or blood, e.g. through organ transplantations and blood transfusions. EBV transmission through oral secretions results in infection of epithelial cells of the oropharynx. From the epithelial cells EBV can infect B cells, which are the major reservoir for the virus, but other cell types may also become infected. As a result, EBV can shuttle between different cell types, mainly B cells and epithelial cells. Moreover, since the virus can switch between a latent and a lytic life cycle, EBV has the ability to cause chronic relapsing\/reactivating infections. Chronic or recurrent EBV infection of epithelial cells has been linked to systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome, whereas chronic\/recurrent infection of B cells has been associated with rheumatoid arthritis, multiple sclerosis and other diseases. Accordingly, since EBV can shuttle between epithelial cells and B cells, the systemic autoimmune diseases often occur as overlapping syndromes with symptoms and characteristic autoantibodies (e.g. antinuclear antibodies and rheumatoid factors) reflecting epithelial and\/or B cell infection.<\/jats:p>","DOI":"10.3389\/fimmu.2020.587380","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T04:02:18Z","timestamp":1609992138000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":338,"title":["Epstein-Barr Virus and Systemic Autoimmune Diseases"],"prefix":"10.3389","volume":"11","author":[{"given":"Gunnar","family":"Houen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Hartwig","family":"Trier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0226436","DOI":"10.1371\/journal.pone.022643","article-title":"Primary Epstein-Barr virus infection with and without infectious mononucleosis","volume":"12","author":"Rostgaard","year":"2019","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-3-319-22822-8_9","article-title":"Infectious Mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J Clin Virol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s1386-6532(01)00149-4","article-title":"Epstein-Barr virus (EBV) infection in infancy","volume":"1","author":"Chan","year":"2001","journal-title":"J Clin Virol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/s0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"7335","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.coi.2020.01.004","article-title":"Human inborn errors of immunity to herpes viruses","volume":"62","author":"Jouanguy","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3851\/IMP1467","article-title":"Herpesviridae and novel inhibitors","volume":"8","author":"Siakallis","year":"2009","journal-title":"Antivir Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e01593","DOI":"10.1128\/JVI.01593-18","article-title":"A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA","volume":"2","author":"Majerciak","year":"2019","journal-title":"J Virol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/cam4.1006","article-title":"Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas","volume":"3","author":"Sakamoto","year":"2017","journal-title":"Cancer Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4161\/rna.27488","article-title":"RNA families in Epstein-Barr virus","volume":"1","author":"Moss","year":"2014","journal-title":"RNA Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1107\/S0907444906030034","article-title":"Structural genomics of the Epstein-Barr virus","volume":"10","author":"Tarbouriech","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545313.023","article-title":"Introduction to the human \u03b3-herpesviruses","volume-title":"Human Herpesviruses","author":"Longnecker","year":"2007"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/cas.13954","article-title":"Epstein-Barr virus strain variation and cancer","volume":"4","author":"Kanda","year":"2019","journal-title":"Cancer Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e01918","DOI":"10.1128\/JVI.01918-19","article-title":"Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells","volume":"94","author":"Delecluse","year":"2020","journal-title":"J Virol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/infdis\/jiy601","article-title":"Differences in the Epstein-Barr Virus gp350 IgA Antibody Response Are Associated With Increased Risk for Coinfection With a Second Strain of Epstein-Barr Virus","volume":"6","author":"Smith","year":"2019","journal-title":"J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jmv.24633","article-title":"Epstein-Barr virus strains and variations: Geographic or disease-specific variants","volume":"3","author":"Neves","year":"2017","journal-title":"J Med Virol"},{"key":"B17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1017\/CBO9780511545313.004","article-title":"Comparative virion structures of human herpesviruses","volume-title":"Human Herpesviruses","author":"Liu","year":"2007"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2217\/fvl.15.80","article-title":"EBV glycoproteins: where are we now","volume":"10","author":"Hutt-Fletcher","year":"2015","journal-title":"Future Virol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00281-020-00792-2","article-title":"Epigenetic lifestyle of Epstein-Barr virus","volume":"42","author":"Buschle","year":"2000","journal-title":"Semin Immunopathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.14348\/molcells.2016.0066","article-title":"Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus","volume":"4","author":"M\u00f6hl","year":"2016","journal-title":"Mol Cells"},{"key":"B21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-3-319-22822-8_6","article-title":"The Epigenetic Life Cycle of Epstein-Barr Virus","volume":"390","author":"Hammerschmidt","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12026-014-8496-1","article-title":"The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease","author":"Hatton","year":"2014","journal-title":"Immunol Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections","volume":"1","author":"Odumade","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1098\/rstb.2000.0783","article-title":"Biology and disease associations of Epstein-Barr virus","volume":"1408","author":"Crawford","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/s0024-3205(99)00214-3","article-title":"A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells","volume":"65","author":"Thorley-Lawson","year":"1999","journal-title":"Life Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.coviro.2013.12.001","article-title":"Epstein Barr virus entry; kissing and conjugation","volume":"4","author":"Shannon-Lowe","year":"2014","journal-title":"Curr Opin Virol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2016.01.010","article-title":"gH\/gL supercomplexes at early stages of herpesvirus entry","volume":"18","author":"Heldwein","year":"2016","journal-title":"Curr Opin Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.5732\/cjc.014.10168","article-title":"Epstein-Barr virus infection mechanisms","volume":"33","author":"Chesnokova","year":"2014","journal-title":"Chin J Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41564-017-0080-8","article-title":"Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat Microbiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41564-017-0081-7","article-title":"Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus","volume":"3","author":"Chen","year":"2018","journal-title":"Nat Microbiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/ijms19010317","article-title":"Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to rheumatoid arthritis","volume":"1","author":"Trier","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/femsre\/fuz023","article-title":"Epithelial cell infection by Epstein-Barr virus","volume":"43","author":"Chen","year":"2019","journal-title":"FEMS Microbiol Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1128\/JVI.71.1.519-526.1997","article-title":"Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus","volume":"71","author":"Gan","year":"1997","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.virol.2007.09.012","article-title":"The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells","volume":"370","author":"Xiao","year":"2008","journal-title":"Virology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1038\/ncomms7240","article-title":"Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"11036","DOI":"10.1073\/pnas.1513359112","article-title":"Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells","volume":"112","author":"Xiong","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e01255","DOI":"10.1128\/JVI.01255-17","article-title":"Epstein-Barr Virus Fusion with Epithelial Cells Triggered by gB Is Restricted by a gL Glycosylation Site","volume":"91","author":"M\u00f6hl","year":"2017","journal-title":"J Virol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1004309","DOI":"10.1371\/journal.ppat.1004309","article-title":"Assembly and architecture of the EBV B cell entry triggering complex","volume":"10","author":"Sathiyamoorthy","year":"2014","journal-title":"PLoS Pathog"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13557","DOI":"10.1038\/ncomms13557","article-title":"Structural basis for Epstein-Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins","volume":"7","author":"Sathiyamoorthy","year":"2016","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1128\/JVI.79.6.3703-3712.2005","article-title":"BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress","volume":"79","author":"Farina","year":"2005","journal-title":"J Virol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1128\/JVI.02436-07","article-title":"Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles","volume":"82","author":"Granato","year":"2008","journal-title":"J Virol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02193","article-title":"The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog","volume":"10","author":"Long","year":"2019","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/imr.12791","article-title":"Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases","volume":"1","author":"Latour","year":"2019","journal-title":"Immunol Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01658","article-title":"Epstein-Barr Virus-Specific Immune Control by Innate Lymphocytes","volume":"8","author":"M\u00fcnz","year":"2017","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-3-319-22834-1_10","article-title":"Epstein-Barr Virus-Specific Humoral Immune Responses in Health and Disease","volume":"391","author":"Middeldorp","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1189\/jlb.0313173","article-title":"Innate immune responses against Epstein Barr virus infection","volume":"6","author":"Chijioke","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00367","article-title":"Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases","volume":"11","author":"Iizasa","year":"2020","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/microorganisms7060183","article-title":"Epstein-Barr Virus and Innate Immunity: Friends or Foes","volume":"6","author":"Jangra","year":"2019","journal-title":"Microorganisms"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e01667","DOI":"10.1128\/JVI.01667-16","article-title":"MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity","volume":"16","author":"Albanese","year":"2017","journal-title":"J Virol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-3-319-22834-1_12","article-title":"Immune Evasion by Epstein-Barr Virus","volume":"391","author":"Ressing","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.micinf.2009.12.001","article-title":"Immune responses to Epstein-Barr virus: molecular interactions in the virus invasion of CD8+ T cell immunity","volume":"3","author":"Rowe","year":"2010","journal-title":"Microbes Infect"},{"key":"B52","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","article-title":"Latency and lytic replication in Epstein-Barr virus-associated oncogenesis","volume":"17","author":"M\u00fcnz","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.coviro.2015.09.007","article-title":"Epstein-Barr virus latency: current and future perspectives","volume":"14","author":"Kempkes","year":"2015","journal-title":"Curr Opin Virol"},{"key":"B54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1017\/CBO9780511545313.025","article-title":"Maintenance and replication during latency","volume-title":"Human Herpesviruses","author":"Liebermann","year":"2007"},{"key":"B55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jclinpath-2019-205822","article-title":"Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors","volume":"10","author":"Kerr","year":"2019","journal-title":"J Clin Pathol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/1348-0421.12155","article-title":"Regulation of Epstein-Barr virus reactivation from latency","volume":"6","author":"Murata","year":"2014","journal-title":"Microbiol Immunol"},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545313.026","article-title":"Reactivation and lytic replication of EBV","volume-title":"Human Herpesviruses","author":"Kenney","year":"2007"},{"key":"B58","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-12-800098-4.00006-4","article-title":"Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation","volume":"88","author":"Price","year":"2014","journal-title":"Adv Virus Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/cancers10040109","article-title":"EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers","volume":"10","author":"Wilson","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/ncomms16043","article-title":"Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA","volume":"8","author":"Lista","year":"2017","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/path.4431","article-title":"Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers","volume":"235","author":"Daskalogianni","year":"2015","journal-title":"J Pathol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1128\/JVI.02183-15","article-title":"The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II","volume":"90","author":"Quinn","year":"2015","journal-title":"J Virol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"11583","DOI":"10.1073\/pnas.2034960100","article-title":"Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition","volume":"100","author":"Ressing","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B64","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1128\/JVI.79.2.841-852.2005","article-title":"Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion","volume":"79","author":"Ressing","year":"2005","journal-title":"J Virol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1084\/jem.20070256","article-title":"A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates","volume":"204","author":"Hislop","year":"2007","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1073\/pnas.0611128104","article-title":"Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion","volume":"104","author":"Rowe","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1000255","DOI":"10.1371\/journal.ppat.1000255","article-title":"The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation","volume":"5","author":"Zuo","year":"2009","journal-title":"PLoS Pathog"},{"key":"B68","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1099\/jgv.0.000021","article-title":"Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion","volume":"96","author":"van Gent","year":"2015","journal-title":"J Gen Virol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1003960","DOI":"10.1371\/journal.ppat.1003960","article-title":"Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling","volume":"10","author":"van Gent","year":"2014","journal-title":"PLoS Pathog"},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545313.032","article-title":"Human gammaherpesvirus immune evasion strategies","volume-title":"Human Herpesviruses","author":"Means","year":"2007"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e01707","DOI":"10.1128\/mBio.01707-18","article-title":"Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation","volume":"10","author":"Fares","year":"2019","journal-title":"mBio"},{"key":"B72","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1126\/science.2161559","article-title":"Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI","volume":"248","author":"Moore","year":"1990","journal-title":"Science"},{"key":"B73","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/viro.2002.1716","article-title":"Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV","volume":"304","author":"Salek-Ardakani","year":"2002","journal-title":"Virology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"26586","DOI":"10.1074\/jbc.M112.376707","article-title":"Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties","volume":"287","author":"Yoon","year":"2012","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02198","article-title":"Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes","volume":"9","author":"Jog","year":"2018","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/vim.2012.0034","article-title":"Epstein-Barr virus-encoded BARF1 protein is a decoy receptor or macrophage colony stimulating factor and interferes with macrophage differentiation and activation","volume":"25","author":"Hoebe","year":"2012","journal-title":"Viral Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nsmb.2367","article-title":"Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1","volume":"19","author":"Elegheert","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1128\/jvi.76.18.9232-9241.2002","article-title":"Herpes simplex virus type 1 evades the effects of antibody and complement in vivo","volume":"76","author":"Lubinski","year":"2002","journal-title":"J Virol"},{"key":"B79","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545313","volume-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","author":"Arvin","year":"2007"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e1005550","DOI":"10.1371\/journal.ppat.1005550","article-title":"The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells","volume":"12","author":"Gram","year":"2016","journal-title":"PLoS Pathog"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00127","article-title":"Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders","volume":"9","author":"Dugan","year":"2019","journal-title":"Front Oncol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/rmv.1816","article-title":"Host genetics of Epstein-Barr virus infection, latency and disease","volume":"20152","author":"Houldcroft","year":"2015","journal-title":"Rev Med Virol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1086\/314883","article-title":"Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection","volume":"180","author":"Helminen","year":"1999","journal-title":"J Infect Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1073858410381531","article-title":"The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis","volume":"17","author":"Pender","year":"2011","journal-title":"Neuroscientist"},{"key":"B85","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/ene.12620","article-title":"Obesity interacts with infectious mononucleosis in risk of multiple sclerosis","volume":"22","author":"Hedstr\u00f6m","year":"2015","journal-title":"Eur J Neurol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5604\/01.3001.0010.6287","article-title":"Comparison of Methods Used for the Diagnosis of Epstein-Barr Virus Infections in Children","volume":"1","author":"Kasifoglu","year":"2018","journal-title":"Pol J Microbiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"E5115","DOI":"10.1073\/pnas.1804184115","article-title":"Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma","volume":"22","author":"Lam","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B88","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12879-017-2412-y","article-title":"Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients","volume":"1","author":"Cao","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jviromet.2017.02.016","article-title":"Analysis of BZLF1 mRNA detection in saliva as a marker for active replication of Epstein-Barr virus","volume":"244","author":"Fagin","year":"2017","journal-title":"J Virol Methods"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e0120710","DOI":"10.1371\/journal.pone.0120710","article-title":"Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjects","volume":"3","author":"Kwok","year":"2015","journal-title":"PLoS One"},{"key":"B91","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jcv.2003.10.002","article-title":"Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma","volume":"2","author":"Fafi-Kremer","year":"2004","journal-title":"J Clin Virol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1525-1578(10)60642-3","article-title":"Molecular Diagnosis of Epstein-Barr Virus-Related Diseases","volume":"3","author":"Gulley","year":"2001","journal-title":"J Mol Diagn"},{"key":"B93","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5501\/wjv.v1.i1.31","article-title":"Serological diagnosis of Epstein-Barr virus infection: Problems and solutions","volume":"1","author":"De Paschale","year":"2012","journal-title":"World J Virol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/00365513.2018.1550807","article-title":"Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology","author":"Sternb\u00e6k","year":"2019","journal-title":"Scand J Clin Lab Invest"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/infdis\/jiy122","article-title":"Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome","volume":"12","author":"Liu","year":"2018","journal-title":"J Infect Dis"},{"key":"B96","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/1096-9071(200104)63:4<271::aid-jmv1001>3.0.co;2-t","article-title":"Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18","volume":"63","author":"F\u00e4rber","year":"2001","journal-title":"J Med Virol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/infdis\/170.1.13","article-title":"Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein","volume":"1","author":"van Grunsven","year":"1994","journal-title":"J Infect Dis"},{"key":"B98","first-page":"83","article-title":"Diagnosis of Epstein-Barr virus-related diseases","volume":"100","author":"Linde","year":"1996","journal-title":"Scand J Infect Dis Suppl"},{"key":"B99","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","article-title":"Spectrum of Epstein-Barr virus-associated diseases","volume":"1","author":"Kutok","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein-Barr Virus and Cancer","volume":"14","author":"Farrell","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01602","article-title":"Epstein-Barr Virus: Diseases Linked to Infection and Transformation","volume":"7","author":"Jha","year":"2016","journal-title":"Front Microbiol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1158\/1078-0432.CCR-10-2578","article-title":"Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes","volume":"10","author":"Saha","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","first-page":"565","DOI":"10.7150\/ijbs.24562","article-title":"Epstein-Barr virus-encoded microRNAs as regulators in host immune responses","volume":"5","author":"Wang","year":"2018","journal-title":"Int J Biol Sci"},{"key":"B104","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pathol.2019.09.011","article-title":"Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach","volume":"1","author":"Hue","year":"2020","journal-title":"Pathology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1684\/ejd.2018.3490","article-title":"Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders","volume":"1","author":"Iwatsuki","year":"2019","journal-title":"Eur J Dermatol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12016-017-8606-7","article-title":"Myeloid Populations in Systemic Autoimmune Diseases","volume":"2","author":"Morell","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"535738","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"102400","DOI":"10.1016\/j.jaut.2019.102400","article-title":"The etiology of rheumatoid arthritis","volume":"110","author":"Scherer","year":"2020","journal-title":"J Autoimmun"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"10086","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"23","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"102392","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An overview of autoantibodies in rheumatoid arthritis","volume":"110","author":"van Delft","year":"2020","journal-title":"J Autoimmun"},{"key":"B112","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/imr.12829","article-title":"Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology","volume":"1","author":"Volkov","year":"2020","journal-title":"Immunol Rev"},{"key":"B113","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/joim.13058","article-title":"The importance of differences; On environment and its interactions with genes and immunity in the causation of rheumatoid arthritis","volume":"5","author":"Klareskog","year":"2020","journal-title":"J Intern Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jbspin.2017.04.011","article-title":"Epstein-Barr virus and rheumatoid arthritis","volume":"2","author":"Balandraud","year":"2018","journal-title":"Joint Bone Spine"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0208957","DOI":"10.1371\/journal.pone.0208957","article-title":"Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial tissues of rheumatoid arthritis","volume":"12","author":"Masuoka","year":"2018","journal-title":"PLoS One"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02940.x","article-title":"Early environmental factors and rheumatoid arthritis","volume":"1","author":"Edwards","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1093\/rheumatology\/keaa232","article-title":"The genetics of rheumatoid arthritis","volume":"59","author":"Dedmon","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B118","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2474-9-52","article-title":"Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety","volume":"9","author":"Alonso-Ruiz","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"key":"B119","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13075-015-0755-6","article-title":"Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis","volume":"17","author":"Ball","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1038\/s41598-018-22058-6","article-title":"Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis","volume":"1","author":"Trier","year":"2018","journal-title":"Sci Rep"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01853","article-title":"The Infectious Basis of ACPA-positive Rheumatoid Arthritis","volume":"8","author":"Sakkas","year":"2017","journal-title":"Front Microbiol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jbspin.2018.03.017","article-title":"Anti PAD autoimmunity and rheumatoid arthritis","volume":"85","author":"Roudier","year":"2018","journal-title":"Joint Bone Spine"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e0217624","DOI":"10.1371\/journal.pone.0217624","article-title":"Immunoglobulin G structure and rheumatoid factor epitopes","volume":"6","author":"Maibom-Thomsen","year":"2019","journal-title":"PLoS One"},{"key":"B124","first-page":"778","article-title":"Serun Epstein-Barr virus DNA, detected by droplet digital PCR, correlates with disease activity in patients with rheumatoid arthritis","volume":"5","author":"Kuusela","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1136\/annrheumdis-2012-202352","article-title":"Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis","volume":"9","author":"Croia","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B126","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/modpathol.3800119","article-title":"Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization","volume":"7","author":"Mehraein","year":"2004","journal-title":"Mod Pathol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/1756-185X.13839","article-title":"Update on disease pathogenesis, diagnosis, and management of primary Sj\u00f6gren\u2019s syndrome","volume":"6","author":"Wang","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"B128","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0961203318801673","article-title":"Primary Sj\u00f6gren\u2019s syndrome","volume":"27","author":"Bowman","year":"2018","journal-title":"Lupus"},{"key":"B129","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/joim.13032","article-title":"Environmental factors in the pathogenesis of primary Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Bj\u00f6rk","year":"2020","journal-title":"J Intern Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.trsl.2006.07.003","article-title":"Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sj\u00f6gren\u2019s syndrome","volume":"6","author":"Nakamura","year":"2006","journal-title":"Transl Res"},{"key":"B131","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clim.2017.04.018","article-title":"Genetics of Sj\u00f6gren\u2019s syndrome","volume":"182","author":"Teos","year":"2017","journal-title":"Clin Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1600-0420.1995.tb00302.x","article-title":"Increased levels of Epstein-Barr virus DNA in lacrimal glands of Sjogren\u2019s syndrome patients","volume":"73","author":"Tsubota","year":"1995","journal-title":"Acta Ophthalmol Scand"},{"key":"B133","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/BOR.0000000000000622","article-title":"The role of Epstein-Barr virus infection in primary Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Ma\u015bli\u0144ska","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"9","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: Diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J Autoimmun"},{"key":"B136","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.autrev.2015.02.008","article-title":"Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows","volume":"7","author":"Ceccarelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"10188","author":"Durcan","year":"2019","journal-title":"Lancet"},{"key":"B139","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/0961203318817132","article-title":"Disease course patterns in systemic lupus erythematosus","volume":"1","author":"Tselios","year":"2019","journal-title":"Lupus"},{"key":"B140","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/1744666X.2020.1745063","article-title":"Revisiting the complement system in systemic lupus erythematosus","volume":"4","author":"Sharma","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"102356","DOI":"10.1016\/j.jaut.2019.102356","article-title":"Evolving story of autoantibodies in systemic lupus erythematosus","volume":"110","author":"Pisetsky","year":"2020","journal-title":"J Autoimmun"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1515\/cclm-2019-0638","article-title":"Changes in the result of antinuclear antibody immunofluorescence assay on HEp-2 cells reflect disease activity status in systemic lupus erythematosus","volume":"8","author":"Prado","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"939","DOI":"10.12688\/f1000research.6875.1","article-title":"Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosus","volume":"4","author":"Fu","year":"2015","journal-title":"F1000Res"},{"key":"B144","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic exPLoSion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"1","author":"Yaniv","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/cells8101180","article-title":"Update on the Genetics of Systemic Lupus Erythematosus: Genome-Wide Association Studies and Beyond","volume":"10","author":"Kwon","year":"2019","journal-title":"Cells"},{"key":"B146","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaut.2015.08.004","article-title":"Immunogenetics of systemic lupus erythematosus: A comprehensive review","volume":"64","author":"Ghodke-Puranik","year":"2015","journal-title":"J Autoimmun"},{"key":"B147","doi-asserted-by":"publisher","first-page":"102392","DOI":"10.1016\/j.autrev.2019.102392","article-title":"Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis","volume":"11","author":"Islam","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B148","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10238-018-0535-0","article-title":"The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis","volume":"1","author":"Li","year":"2019","journal-title":"Clin Exp Med"},{"key":"B149","doi-asserted-by":"publisher","first-page":"102393","DOI":"10.1016\/j.autrev.2019.102393","article-title":"Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: A systematic review and meta-analysis","volume":"11","author":"Parisis","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B150","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.berh.2017.09.005","article-title":"Understanding the role of environmental factors in the development of systemic lupus erythematosus","volume":"3","author":"Parks","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/BOR.0000000000000318","article-title":"Environmental exposures and the development of systemic lupus erythematosus","volume":"5","author":"Barbhaiya","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"370516","DOI":"10.1155\/2012\/370516","article-title":"Epstein-Barr virus and systemic lupus erythematosus","volume":"2012","author":"Draborg","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/01.bor.0000240355.37927.94","article-title":"Epstein-Barr virus and systemic lupus erythematosus","volume":"5","author":"James","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08916930500484849","article-title":"Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus","volume":"1","author":"Poole","year":"2006","journal-title":"Autoimmunity"},{"key":"B155","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry","volume":"1","author":"McClain","year":"2005","journal-title":"Nat Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e000015","DOI":"10.1136\/lupus-2014-000015","article-title":"Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients","volume":"1","author":"Draborg","year":"2014","journal-title":"Lupus Sci Med"},{"key":"B157","doi-asserted-by":"publisher","first-page":"6473204","DOI":"10.1155\/2016\/6473204","article-title":"Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients","volume":"2016","author":"Draborg","year":"2016","journal-title":"J Immunol Res"},{"key":"B158","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3109\/08830185.2013.863305","article-title":"Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus","volume":"4","author":"Caza","year":"2014","journal-title":"Int Rev Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s10096-014-2098-7","article-title":"Infections and systemic lupus erythematosus","volume":"9","author":"Esposito","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B160","doi-asserted-by":"publisher","first-page":"101472","DOI":"10.1016\/j.berh.2019.101472","article-title":"The relationships between cancer and autoimmune rheumatic diseases","volume":"1","author":"Cappelli","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/cells9020462","article-title":"The Role of Gamma Delta T Cells in Autoimmune Rheumatic Diseases","volume":"9","author":"Bank","year":"2020","journal-title":"Cells"},{"key":"B162","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/1756-185X.12298","article-title":"Comparison of plasma vitamin D levels in patients with Sj\u00f6gren\u2019s syndrome and healthy subjects","volume":"18","author":"Erten","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"B163","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3899\/jrheum.180481","article-title":"Association of Smoking and Obesity on the Risk of Developing Primary Sj\u00f6gren Syndrome: A Population-based Cohort Study","volume":"7","author":"Servioli","year":"2019","journal-title":"J Rheumatol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clim.2016.10.015","article-title":"Increased frequency of the PTPN22W* variant in primary Sjogren\u2019s Syndrome: Association with low type I IFN scores","volume":"173","author":"Vlachogiannis","year":"2016","journal-title":"Clin Immunol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/tan.12698","article-title":"Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients","volume":"1","author":"Paradowska-Gorycka","year":"2016","journal-title":"HLA"},{"key":"B166","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/rheumatology\/keu310","article-title":"The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases","volume":"3","author":"Fl\u00e5m","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B167","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/art.30111","article-title":"HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis","volume":"2","author":"Nguyen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B168","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/BOR.0b013e3283367c17","article-title":"The genetics of scleroderma (systemic sclerosis)","volume":"2","author":"Agarwal","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-019-00314-7","article-title":"Prevalence of Epstein-Barr virus infection and characteristics of lymphocyte subsets in newly onset juvenile dermatomyositis","author":"Zheng","year":"2019","journal-title":"World J Pediatr"},{"key":"B170","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.semarthrit.2018.02.003","article-title":"The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis","volume":"3","author":"Schiffenbauer","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"B171","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-5945-14-9","article-title":"HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population","volume":"14","author":"Gao","year":"2014","journal-title":"BMC Dermatol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.1002\/jcp.27860","article-title":"Strategies toward rheumatoid arthritis therapy; the old and the new","volume":"7","author":"Abbasi","year":"2019","journal-title":"J Cell Physiol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-med-070912-133235","article-title":"Anti-B cell antibody therapies for inflammatory rheumatic diseases","volume":"65","author":"Faurschou","year":"2014","journal-title":"Annu Rev Med"},{"key":"B174","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.trsl.2014.09.006","article-title":"Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases","volume":"2","author":"Willrich","year":"2015","journal-title":"Transl Res"},{"key":"B175","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.autrev.2004.10.007","article-title":"Impaired clearance of dying cells in systemic lupus erythematosus","volume":"4","author":"Gaipl","year":"2005","journal-title":"Autoimmun Rev"},{"key":"B176","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies","volume":"26","author":"Bar-Or","year":"2020","journal-title":"Trends Mol Med"},{"key":"B177","article-title":"The onset of active disease in systemic lupus erythematosus patients is characterised by excessive regulatory CD4+-T-cell differentiation","author":"Schaier","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semarthrit.2011.01.008","article-title":"Emerging viral infections in rheumatic diseases","volume":"2","author":"Khasnis","year":"2011","journal-title":"Semin Arthritis Rheumatol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13317-016-0086-x","article-title":"Infections as a cause of autoimmune rheumatic diseases","volume":"1","author":"Sakkas","year":"2016","journal-title":"Auto Immun Highlights"},{"key":"B180","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/BOR.0b013e328333b9f5","article-title":"Update on rheumatic manifestations of infectious diseases","volume":"1","author":"Becker","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"17.1","DOI":"10.1186\/1546-0096-8-17","article-title":"Cytomegalovirus infection in pediatric rheumatic diseases: a review","volume":"8","author":"Eisenstein","year":"2010","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.587380\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T04:02:23Z","timestamp":1609992143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.587380\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":181,"alternative-id":["10.3389\/fimmu.2020.587380"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.587380","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"article-number":"587380"}}